Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: A preliminary report

Journal of AAPOS

Volumn 17, Issue 5, 2013, Pages 460-464

  Saboo, Ujwala S ^a,b   Metzinger, Jamie Lynne ^a,b   Radwan, Alaa ^a,b   Arcinue, Cheryl ^a,b   Parikh, Ravi ^a,c   Mohamed, Ashik ^d   Foster, C Stephen ^a,b,e  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b Massachusetts Eye Research and Surgery Institute   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d L V PRASAD EYE INSTITUTE   (India)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOSPORIN A; GRANULOCYTE ANTIBODY; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; AGE DISTRIBUTION; ANAPHYLAXIS; ANTERIOR EYE CHAMBER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; JUVENILE RHEUMATOID ARTHRITIS; LEUKOPENIA; MALE; MEDICAL RECORD REVIEW; NAUSEA; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL; UVEITIS; VISUAL SYSTEM PARAMETERS; VITREOUS HAZE;

ADOLESCENT; ARTHRITIS, JUVENILE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; MALE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; UVEITIS;

EID: 84886659066     PISSN: 10918531     EISSN: 15283933     Source Type: Journal    
DOI: 10.1016/j.jaapos.2013.06.004     Document Type: Article

References (18)

1. R.K. Saurenmann, A.V. Levin, and B.M. Feldman Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term follow up study Arthritis Rheum 56 2007 647 657
2. Y. Qian, and N.R. Acharya Juvenile idiopathic arthritis-associated uveitis Curr Opin Ophthalmol 21 2010 468 472
3. K. Kotaniemi, A. Savolainen, A. Karma, and K. Aho Recent advances in uveitis of juvenile idiopathic arthritis Surv Ophthalmol 48 2003 489 502
4. A.T. Berk, N. Koçak, and E. Ûnsal Uveitis in juvenile arthritis Ocul Immunol Inflamm 9 2001 243 251
5. L.I. Kump, R.A. Castañeda, S.N. Androudi, G.F. Reed, and C.S. Foster Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis Ophthalmology 113 2006 1874 1877
6. I. Foeldvari, and A. Wierk Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis J Rheumatol 32 2005 362 365
7. A. Reiff, S. Takei, and S. Sadeghi Etanercept therapy in children with treatment-resistant uveitis Arthritis Rheum 44 2001 1411 1415
8. R.A. Cervantes-Castaneda, P. Bhat, E. Fortuna, S. Acevedo, and C.S. Foster Induction of durable remission in ocular inflammatory diseases Eur J Ophthalmol 19 2009 118 123
9. E. Bloch-Michel, and R.B. Nussenblatt International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease Am J Ophthalmol 103 1987 234 235
10. D.A. Jabs, R.B. Nussenblatt, and J.T. Rosenbaum Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop Am J Ophthalmol 140 2005 509 516
11. V. Kalinina Ayuso, E.L. van de Winkel, A. Rothova, and J.H. de Boer Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis Am J Ophthalmol 151 2011 217 222
12. C.L. Vanderlugt, W.S. Begolka, and K.L. Neville The functional significance of epitope spreading and its regulation by co-stimulatory molecules Immunol Rev 164 1998 63 72
13. L.S. Chan, C.J. Vanderlugt, and T. Hashimoto Epitope spreading: lessons from autoimmune skin diseases J Invest Dermatol 110 1998 103 109
14. C.A. Deeg, S.R. Thurau, H. Gerhards, M. Ehrenhofer, G. Wildner, and B. Kaspers Uveitis in horses induced by interphotoreceptor retinoid-binding protein is similar to the spontaneous disease Eur J Immunol 32 2002 2598 2606
15. C.A. Deeg, B. Amann, A.J. Raith, and B. Kaspers Inter- and intramolecular epitope spreading in equine recurrent uveitis Invest Ophthalmol Vis Sci 47 2006 652 656
16. S.D. Anesi, and C.S. Foster Importance of recognizing and preventing blindness from juvenile idiopathic arthritis-associated uveitis Arthritis Care Res (Hoboken) 64 2012 653 657
17. F. Woreta, J.E. Thorne, D.A. Jabs, S.R. Kedhar, and J.P. Dunn Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis (JIA) Am J Ophthalmol 143 2007 647 655
18. A.C. Gregory II, J.H. Kempen, E. Daniel SITE Cohort Study Research Group Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study Ophthalmology 120 2013 186 192